Denali Therapeutics Inc. (DNLI)

AI Score

Unlock

12.79

-0.95 (-6.91%)

At close: Apr 03, 2025, 12:55 PM

Dividends

No dividend history available for Denali Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

DNLI News

Just now · DNLI Begins Rolling BLA Submission for Hunter Syndrome Drug, Stock Up - zacks.com
2 weeks ago · Denali Therapeutics: Vast Pipeline, First Approval Up Ahead - seekingalpha.com
1 week ago · Why You Shouldn't Bet Against Denali (DNLI) Stock - zacks.com
1 month ago · Denali Q4 Earnings Beat Estimates, Hunter Syndrome Drug in Focus - zacks.com
1 month ago · DNLI Reports Upbeat Longer-Term Data From Hunter Syndrome Study - zacks.com
2 months ago · Denali Gains 26.6% in a Year: How Should You Play the Stock? - zacks.com
2 months ago · Why Is Denali Therapeutics Stock Trading Higher On Wednesday? - benzinga.com
2 months ago · Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains - seekingalpha.com
2 months ago · DNLI's Hunter Syndrome Drug Gets Breakthrough Therapy Designation - zacks.com
2 months ago · Denali's ALS Study Fails to Meet Primary and Secondary Endpoints - zacks.com